Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Morningstar, Inc. (MORN), Thomson Reuters Corporation (USA) (TRI): Will FactSet Research Systems Inc. (FDS) Earnings Keep the Stock Soaring?

FactSet Research Systems Inc. (NYSE:FDSwill release its quarterly report on Tuesday, and investors have been heartily enthusiastic about the stock’s potential for growth. With its shares trading at all-time highs, though, FactSet Research Systems Inc. (NYSE:FDS) earnings will need to deliver strong results to justify the favorable impression shareholders currently have.

FactSet Research Systems Inc. (NYSE:FDS)FactSet Research Systems Inc. (NYSE:FDS) provides market information and research primarily to institutional investors, who use its tools to try to stay ahead of their competition. As the amount of available data has increased exponentially, the most valuable element of FactSet’s service is helping its users weed out unimportant noise from the key information that can provide its clients an edge. Let’s take an early look at what’s been happening with FactSet Research Systems Inc. (NYSE:FDS) over the past quarter and what we’re likely to see in its report.

Stats on FactSet Research

Analyst EPS Estimate $1.21
Change From Year-Ago EPS 12%
Revenue Estimate $218.93 million
Change From Year-Ago Revenue 5.4%
Earnings Beats in Past 4 Quarters 2

Source: Yahoo! Finance.

Can FactSet earnings keep growing this quarter?
Analysts have had generally favorable views on FactSet earnings in recent months, boosting their August-quarter estimates by $0.03 per share. The stock has continued to climb higher as well, rising 12% since mid-June.

FactSet came into the current quarter on a somewhat negative note, as the company didn’t manage to grow as quickly in its May quarter as investors had hoped. Net income rose 11% on a 6% jump in sales, but FactSet Research Systems Inc. (NYSE:FDS) noted that the business environment among its client base was relatively weak, especially among those subscribers that provide stock research and strategic-alternatives consulting services.

Some of FactSet’s competitors have struggled in light of the reluctance to invest among individual investors. Morningstar, Inc. (NASDAQ:MORN) has noted difficulty in selling its subscription services, which are largely focused at individual investors, because of overall risk aversion and the low-interest rate environment. Both FactSet and Thomson Reuters Corporation (USA) (NYSE:TRI) have somewhat different exposure to the market than Morningstar, Inc. (NASDAQ:MORN), as Thomson Reuters Corporation (USA) (NYSE:TRI) offers highly specialized products at premium prices to both financial customers and clients in the legal, tax, and accounting business. But all three rely to some extent on healthy financial markets to drive success.

But those conditions haven’t stopped FactSet from taking steps to boost its business. Earlier this month, FactSet bought Revere Data, adding its proprietary classification system and database on intercorporate relationships to FactSet’s broader offerings. The move is designed to help clients draw conclusions from FactSet Research Systems Inc. (NYSE:FDS)’s data with greater insight.

In the FactSet earnings report, watch to see whether subscriptions start to show faster growth prospects. Without a steady of flow of new customers, it’ll be hard for FactSet to sustain the growth that supports its currently hefty stock valuation.

The article Will FactSet Earnings Keep the Stock Soaring? originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter: @DanCaplinger. The Motley Fool recommends FactSet Research Systems and Morningstar.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!